Dambkowski Carl's Form 4 filing
Apogee Therapeutics, Inc. (APGE) · filed Aug 8, 2025
- Accession no.
- 0001104659-25-075801
- Filed
- Aug 8, 2025
- Trade date
- Aug 6, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $103.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dambkowski CarlCIK 0001983476 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2025 | Common Stock | SSaleDisposed | −2,725 | $37.78 | −$102,950.5 | 236,273 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.